A detailed history of Ancora Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, Ancora Advisors, LLC holds 1,553 shares of HLN stock, worth $14,489. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,553
Previous 1,554 0.06%
Holding current value
$14,489
Previous $12,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$8.32 - $10.7 $8 - $10
-1 Reduced 0.06%
1,553 $16,000
Q2 2024

Aug 14, 2024

SELL
$8.01 - $8.64 $2,403 - $2,592
-300 Reduced 16.18%
1,554 $12,000
Q2 2023

Aug 14, 2023

SELL
$8.04 - $9.0 $56 - $63
-7 Reduced 0.38%
1,854 $15,000
Q1 2023

May 15, 2023

SELL
$7.57 - $8.37 $8,334 - $9,215
-1,101 Reduced 37.17%
1,861 $15,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.06 $4,470 - $6,045
750 Added 33.91%
2,962 $24,000
Q3 2022

Nov 14, 2022

BUY
$5.63 - $7.5 $12,453 - $16,590
2,212 New
2,212 $13,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.1B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.